Skip to main content
. 2003 Aug 26;89(5):795–802. doi: 10.1038/sj.bjc.6601217

Figure 1.

Figure 1

Treatment scheme of the phase I/II study of concurrent chemoradiotherapy with cisplatin and docetaxel in patients with advanced NSCLC. The arrow indicates shrinkage of the radiation field at a total dose of 40 Gy.